Debra N. Yeboa, M.D.

Peer-Reviewed Articles

1. Razavi A, Rooney MK, Fuller CD, Yu JB, Pfister NT, Thomas CR Jr, Buatti JM, Kamran SC, McGee HM, Yeboa DN, Kiess AP, Baschnagel AM, Kimple RJ. National Institutes of Health Funding to Support Radiation Oncology Research: A Comparative Trend Analysis Over a Decade, 2011-2021. Adv Radiat Oncol 10(6):101767, 2025. e-Pub 2025. PMID: 40330712.
2. Matsui JK, Swanson D, Allen P, Perlow HK, Bradshaw J, Beckham TH, Tom MC, Wang C, Perni S, Yeboa DN, Ghia AJ, McAleer MF, Li J, Palmer JD, McGovern SL. Reduced Treatment Volumes for Glioblastoma Associated With Lower Rates of Radionecrosis and Lymphopenia: A Pooled Analysis. Adv Radiat Oncol 10(3):101717, 2025. e-Pub 2025. PMID: 40028224.
3. Iskander GM, Cavazos A, Ejezie CL, Cox V, Cheng H, Perez S, Koong AC, Nguyen J, Herman J, Beddar S, Liao Z, Yeboa DN. Protocol-in-a-Day Workshop: Expediting IRB Approval for Junior and Senior Faculty. J Cancer Educ 40(1):11-15, 2025. e-Pub 2025. PMID: 38914893.
4. Yadav D, Upadhyay R, Kumar VA, Chen MM, Johnson JM, Langshaw H, Curl BJ, Farhat M, Talpur W, Beckham TH, Yeboa DN, Swanson TA, Ghia AJ, Li J, Chung C. Additive Value of MR Simulation Prior to Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas. Pract Radiat Oncol 14(6):e449-e457, 2024. e-Pub 2024. PMID: 38685448.
5. Tom MC, Komatineni S, Wang C, de Almeida RAA, Ghia AJ, Beckham TH, Perni S, McAleer MF, Swanson T, Yeboa DN, De BS, Rooney MK, Bishop AJ, Reddy JP, Yang Y, Ludmir EB, Zhang S, Amini B, Alvarez-Breckenridge C, North RY, Rhines LD, Li J, Tatsui CE. Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compression. J Neurooncol 170(2):289-296, 2024. e-Pub 2024. PMID: 39325339.
6. Beckham TH, Rooney MK, Cifter G, Bernard V, McAleer MF, De BS, Tom MC, Perni S, Wang C, Swanson T, Tatsui CE, Alvarez-Breckenridge C, North R, Rhines LD, Tang C, Logothetis C, Amini B, Li J, Yeboa DN, Ghia AJ. Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approach. J Neurosurg Spine 41(3):436-444, 2024. e-Pub 2024. PMID: 38875722.
7. Wang, C, Rooney, MK, Alvarez-Breckenridge, C, Beckham, TH, Chung, C, De, BS, Ghia, AJ, Grosshans, DR, Majd, NK, McAleer, MF, McGovern, SL, North, RY, Paulino, AC, Perni, S, Reddy, JP, Rhines, LD, Swanson, T, Tatsui, CE, Tom, MC, Yeboa, DN, Li, J. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study. Cancers 16(11), 2024. e-Pub 2024. PMID: 38893133.
8. Pabon, CM, Yeboa, DN, O'Brien, BJ, Majd, NK, Wang, C, Murphy, MA. Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement. Journal of Gastrointestinal Oncology 15(3):1331-1340, 2024. e-Pub 2024. PMID: 38989402.
9. Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern SL, Grosshans DR, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W, Ferguson S, Patel CB, Li J, Yeboa DN. Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches. Neurooncol Pract 11(3):266-274, 2024. e-Pub 2024. PMID: 38737610.
10. Wang C, Rooney MK, Alvarez-Breckenridge C, Beckham TH, Chung C, De BS, Ghia AJ, Grosshans DR, Majd NK, McAleer MF, McGovern SL, North RY, Paulino AC, Perni S, Reddy JP, Rhines LD, Swanson TA, Tatsui CE, Tom MC, Yeboa DN, Li J. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational Study. Cancers (Basel) 16(11), 2024. e-Pub 2024. PMID: 38893133.
11. Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS, Rao G, Ferguson SD, Alvarez-Brenkenridge CA, Kim BYS, Heimberger AB, McCutcheon IE, Prabhu SS, Wang CM, Ghia AJ, McGovern SL, Chung C, McAleer MF, Tom MC, Perni S, Swanson TA, Yeboa DN, Briere TM, Huse JT, Fuller GN, Lang FF, Li J, Suki D, Sawaya RE. Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun 15(1):3728, 2024. e-Pub 2024. PMID: 38697991.
12. Shanker MD, Cavazos AP, Li J, Beckham TH, Yeboa DN, Wang C, McAleer MF, Briere TM, Amini B, Tatsui CE, North RY, Alvarez-Breckenridge CA, Cezayirli PC, Rhines LD, Ghia AJ, Bishop AJ. Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk. Radiother Oncol 193:110119, 2024. e-Pub 2024. PMID: 38311030.
13. Sherry AD, Maroongroge S, De B, Amini B, Conley AP, Bishop AJ, Wang C, Beckham T, Tom M, Briere T, Li J, Yeboa DN, McAleer MF, North R, Tatsui CE, Rhines LD, Ghia AJ. Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol 164(2):377-386, 2023. e-Pub 2023. PMID: 37667065.
14. Altan M, Wang Y, Song J, Welsh J, Tang C, Guha-Thakurta N, Blumenschein GR, Carter BW, Wefel JS, Ghia AJ, Yeboa DN, McAleer MF, Chung C, Woodhouse KD, McGovern SL, Wang C, Kim BYS, Weinberg JS, Briere TM, Elamin YY, Le X, Cascone T, Negrao MV, Skoulidis F, Ferrarotto R, Heymach JV, Li J. Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial. J Immunother Cancer 11(7), 2023. e-Pub 2023. PMID: 37402581.
15. Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen RR, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg JS, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes In Outcomes And Factors Associated With Survival In Melanoma Patients With Brain Metastases. Neuro Oncol 25(7):1310-1320, 2023. e-Pub 2023. PMID: 36510640.
16. McGovern SL, Luo D, Johnson J, Nguyen K, Li J, McAleer MF, Yeboa DN, Grosshans DR, Ghia AJ, Chung C, Bishop AJ, Song J, Thall PF, Brown PD, Mahajan A. A Prospective Study of Conventionally Fractionated Dose Constraints for Re-Irradiation of Primary Brain Tumors in Adults. Pract Radiat Oncol 13(3):231-238, 2023. e-Pub 2023. PMID: 36596356.
17. Florez MA, De B, Chapman BV, Prayongrat A, Thomas JG, Beckham TH, Wang C, Yeboa DN, Bishop AJ, Briere T, Amini B, Li J, Tatsui CE, Rhines LD, Ghia AJ. Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases. Radiat Oncol J 41(1):12-22, 2023. e-Pub 2023. PMID: 37013414.
18. Florez MA, De B, Cavazos A, Farooqi A, Beckham TH, Wang C, Yeboa DN, Bishop AJ, McAleer MF, Briere T, Amini B, Li J, Tatsui CE, Rhines LD, Ghia AJ. Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol 13(1):e7-e13, 2023. e-Pub 2023. PMID: 36604100.
19. Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK. Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. Neurooncol Adv 5(1):vdad032, 2023. e-Pub 2023. PMID: 37114244.
20. Ziyaee H, Cardenas CE, Yeboa DN, Li J, Ferguson SD, Johnson J, Zhou Z, Sanders J, Mumme R, Court L, Briere T, Yang J. Automated Brain Metastases Segmentation With a Deep Dive Into False-positive Detection. Adv Radiat Oncol 8(1):101085, 2023. e-Pub 2023. PMID: 36299565.
21. Quan E, Krafft SP, Briere TM, Vaccarelli MJ, Ghia AJ, Bishop AJ, Yeboa DN, Swanson TA, Han EY. Comparison of setup accuracy and efficiency between the Klarity system and BodyFIX system for spine stereotactic body radiation therapy. J Appl Clin Med Phys 23(11):e13804, 2022. e-Pub 2022. PMID: 36210179.
22. Han EY, Yeboa DN, Briere TM, Yang J, Wang H. Dosimetric analysis of MR-LINAC treatment plans for salvage spine SBRT re-irradiation. J Appl Clin Med Phys 23(10):e13752, 2022. e-Pub 2022. PMID: 36004700.
23. Halasz LM, Attia A, Bradfield L, Brat DJ, Kirkpatrick JP, Laack NN, Lalani N, Lebow ES, Liu AK, Niemeier HM, Palmer JD, Peters KB, Sheehan J, Thomas RP, Vora SA, Wahl DR, Weiss SE, Yeboa DN, Zhong J, Shih H. Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol 12(5):370-386, 2022. e-Pub 2022. PMID: 35902341.
24. Upadhyay R, Liao K, Grosshans DR, McGovern SL, McAleer MF, Zaky W, Chintagumpala MM, Mahajan A, Yeboa DN, Paulino AC. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol 24(9):1571-1581, 2022. e-Pub 2022. PMID: 35157767.
25. De B, Venkatesan AM, Msaouel P, Ghia AJ, Li J, Yeboa DN, Nguyen QN, Bishop AJ, Jonasch E, Shah AY, Campbell MT, Wang J, Zurita-Saavedra AJ, Karam JA, Wood CG, Matin SF, Tannir NM, Tang C. Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation. BJU Int 129(5):610-620, 2022. e-Pub 2022. PMID: 34228889.
26. Han EY, Wang H, Briere TM, Yeboa DN, Boursianis T, Kalaitzakis G, Pappas E, Castillo P, Yang J. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: An end-to-end test. J Appl Clin Med Phys 23(3):e13518, 2022. e-Pub 2022. PMID: 34994101.
27. Upadhyay R, Khose S, Pokhylevych H, Paulino AC, McAleer MF, Ghia A, Li J, Yeboa DN, Loghin M, Harrison R, O'Brien B, Kamiya-Matsuoka C, De Groot J, Puduvalli VK, Tatsui C, Alvarez-Breckenridge C, Prabhu S, Rhines L, Zaky W, Lin F, Weinberg JS, Fuller G, Sandberg DI, Johnson JM, McGovern SL. Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis. Neurooncol Adv 4(1):vdac129, 2022. e-Pub 2022. PMID: 36128585.
28. Han EY, Cardenas CE, Nguyen C, Hancock D, Xiao Y, Mumme R, Court LE, Rhee DJ, Netherton TJ, Li J, Yeboa DN, Wang C, Briere TM, Balter P, Martel MK, Wen Z. Clinical implementation of automated treatment planning for whole-brain radiotherapy. J Appl Clin Med Phys 22(9):94-102, 2021. e-Pub 2021. PMID: 34250715.
29. Thrower SL, Al Feghali KA, Luo D, Paddick I, Hou P, Briere T, Li J, McAleer MF, McGovern SL, Woodhouse KD, Yeboa DN, Brock KK, Chung C. The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery. Adv Radiat Oncol 6(4):100708, 2021. e-Pub 2021. PMID: 34124413.
30. Nantavithya C, Paulino AC, Liao K, Woodhouse KD, McGovern SL, Grosshans DR, McAleer MF, Khatua S, Chintagumpala MM, Majd N, Zaky W, Yeboa DN. Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis. Cancer 127(13):2368-2375, 2021. e-Pub 2021. PMID: 33721338.
31. Patil N, Kelly ME, Yeboa DN, Buerki RA, Cioffi G, Balaji S, Ostrom QT, Kruchko C, Barnholtz-Sloan J. Epidemiology of Brainstem High-Grade Gliomas in Children and Adolescents in the United States, 2000-2017. Neuro Oncol 23(6):990-998, 2021. e-Pub 2020. PMID: 33346835.
32. Yeboa DN, Akinfenwa CA, Nguyen J, Amaya D, de Gracia B, Ning M, Cox V, De B, Smith BD, Lin L, Beddar S, Hoang H, Koong A, Liao Z. Effectively Conducting Oncology Clinical Trials during the COVID-19 Pandemic. Adv Radiat Oncol 6(3):100676, 2021. e-Pub 2021. PMID: 33686374.
33. Taku N, Woodhouse KD, Liao KP, Anakwenze CP, Harrison RA, Zaky W, Paulino AC, Yeboa DN. Patterns of care for pediatric patients with newly-diagnosed grade II gliomas. Childs Nerv Syst 37(5):1563-1572, 2021. e-Pub 2021. PMID: 33404712.
34. Bastos DCA, Vega RA, Traylor JI, Ghia AJ, Li J, Oro M, Bishop AJ, Yeboa DN, Amini B, Kumar VA, Rao G, Rhines LD, Tatsui CE. Spinal laser interstitial thermal therapy: single-center experience and outcomes in the first 120 cases. J Neurosurg Spine 34(3):354-363, 2021. e-Pub 2020. PMID: 33307530.
35. Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Garcia MM, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado M. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. Neurooncol Adv 3(1):vdab079, 2021. e-Pub 2021. PMID: 34377987.
36. Lin TA, Ludmir EB, Liao KP, McAleer MF, Bishop AJ, Grosshans D, McGovern S, Woodhouse KD, Paulino AC, Yeboa DN. Relationship between treatment center case volume and survival for localized Ewing sarcoma: The role of radiotherapy timing. Pediatr Blood Cancer 67(11):e28685, 2020. e-Pub 2020. PMID: 32881378.
37. Diao K, Song J, Thall PF, McGinnis GJ, Boyce-Fappiano D, Amini B, Brown PD, Yeboa DN, Bishop AJ, Li J, Briere TM, Tatsui CE, Rhines LD, Chang EL, Ghia AJ. Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. Radiother Oncol 152:49-55, 2020. e-Pub 2020. PMID: 32745668.
38. Yeboa DN, Gibbs IC. Stereotactic Radiotherapy and Resection of Brain Metastases: The Role of Hypofractionation. JAMA Oncol. e-Pub 2020. PMID: 33057588.
39. Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg 141:e133-e144, 2020. e-Pub 2020. PMID: 32407910.
40. Nantavithya C, Paulino AC, Liao K, McGovern SL, Grosshans DR, McAleer MF, Woodhouse KD, Khatua S, Chintagumpala MM, Majd NK, Yeboa DN. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer 67(8):e28373, 2020. e-Pub 2020. PMID: 32453481.
41. Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol 5(4):743-745, 2020. e-Pub 2020. PMID: 32775785.
42. Gjyshi O, Boyce-Fappiano D, Pezzi TA, Ludmir EB, Xiao L, Kaseb A, Amini B, Yeboa DN, Bishop AJ, Li J, Rhines LD, Tatsui CE, Briere TM, Ghia AJ. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol 148(2):327-334, 2020. e-Pub 2020. PMID: 32358642.
43. Milligan MG, Cronin AM, Colson Y, Kehl K, Yeboa DN, Schrag D, Chen AB. Overuse of Diagnostic Brain Imaging Among Patients With Stage IA Non-Small Cell Lung Cancer. J Natl Compr Canc Netw 18(5):547-554, 2020. e-Pub 2020. PMID: 32380461.
44. Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Exclusion of Patients with Brain Metastases from Cancer Clinical Trials. Neuro Oncol 22(4):577-579, 2020. e-Pub 2020. PMID: 31900480.
45. Boyce-Fappiano D, Gjyshi O, Pezzi TA, Allen PK, Solimman M, Taku N, Bernstein MB, Cabanillas ME, Amini B, Tatsui CE, Rhines LD, Wang XA, Briere TM, Yeboa DN, Bishop AJ, Li J, Ghia AJ. Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience. J Neurosurg Spine:1-9. e-Pub 2020. PMID: 32059183.
46. Cioffi G, Yeboa DN, Kelly M, Patil N, Manzoor N, Greppin K, Takaoka K, Waite K, Kruchko C, Barnholtz-Sloan JS. Epidemiology of vestibular schwannoma in the United States, 2004-2016. Neurooncol Adv 2(1):vdaa135, 2020. e-Pub 2020. PMID: 33241216.
47. de Almeida Bastos DC, Everson RG, de Oliveira Santos BF, Habib A, Vega RA, Oro M, Rao G, Li J, Ghia AJ, Bishop AJ, Yeboa DN, Amini B, Rhines LD, Tatsui CE. A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression. J Neurosurg Spine:1-9. e-Pub 2020. PMID: 31899882.
48. Han EY, Aima M, Hughes N, Briere TM, Yeboa DN, Castillo P, Wang J, Yang J, Vedam S. Feasibility of spinal stereotactic body radiotherapy in Elekta Unity® MR-Linac. J Radiosurg SBRT 7(2):127-134, 2020. e-Pub 2020. PMID: 33282466.
49. Shaverdian N, Yeboa DN, Gardner L, Harari PM, Liao K, McCloskey S, Tuli R, Vapiwala N, Jagsi R. Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences. J Oncol Pract 15(12):e1010-e1017, 2019. e-Pub 2019. PMID: 31747336.
50. Traylor JI, Habib A, Patel R, Muir M, Gadot R, Briere T, Yeboa DN, Li J, Rao G. Fractionated stereotactic radiotherapy for local control of resected brain metastases. J Neurooncol 144(2):343-350, 2019. e-Pub 2019. PMID: 31313060.
51. Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol 16(8):521-522, 2019. e-Pub 2019. PMID: 31150024.
52. Yeboa DN, Liao Z, Court L, Holliday EB, Spelman A, Herman J. Protocol-in-a-Day Workshop: A Lean Approach to Clinical Trial Development and Focus on Junior Faculty Development. Adv Radiat Oncol 4(3):439-442, 2019. e-Pub 2019. PMID: 31360796.
53. Lin TA, Ludmir EB, Liao KP, McAleer MF, Grosshans DR, McGovern SL, Bishop AJ, Woodhouse KD, Paulino AC, Yeboa DN. Timing of Local Therapy Impacts Survival in Ewing Sarcoma. Int J Radiat Oncol Biol Phys 104(1):127-136, 2019. e-Pub 2019. PMID: 30593906.
54. Rahimy E, Weidhaas J, Wei W, Lannin D, Horowitz N, Higgins S, Wilson LD, Knowlton C, Moran MS, Young MR, Killelea B, Chagpar A, Yeboa DN, Zelterman D, Evans S. Patient Reported Outcomes and Cosmesis in a Feasibility Study of 4D Simulated Image Guided Accelerated Partial Breast Irradiation (APBI). Pract Radiat Oncol 9(3):e257-e265, 2019. e-Pub 2019. PMID: 30796975.
55. Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clin Transl Radiat Oncol 15:46-52, 2019. e-Pub 2019. PMID: 30656222.
56. Yeboa DN, Liao KP, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines LD, Ferguson S, Paulino AC, Ghia AJ. National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas. World Neurosurg. e-Pub 2019. PMID: 30641236.
57. Miccio JA, Wilson LD, Kann BH, Jairam V, Beckta J, Foss FM, Yeboa DN. Cutaneous T-Cell Lymphoma: Trends in Radiation Doses and Patterns of Care 2004-2015. Anticancer Res 39(1):253-259, 2019. e-Pub 2019. PMID: 30591466.
58. Han EY, Kim GY, Rebueno N, Yeboa DN, Briere TM. End-to-end testing of automatic plan optimization using RayStation scripting for hypofractionated multi-metastatic brain stereotactic radiosurgery. Med Dosim 44(4):e44-e50, 2019. e-Pub 2019. PMID: 30655170.
59. Al Feghali KA, Yeboa DN, Chasen B, Gule MK, Johnson JM, Chung C. The Use of 68Ga-DOTATATE PET/CT in the Non-Invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. Front Oncol 8:454, 2018. e-Pub 2018. PMID: 30386741.
60. Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas. Radiother Oncol 125(2):258-265, 2017. e-Pub 2017. PMID: 29054377.
61. Kann BH, Park HS, Yeboa DN, Aneja S, Girardi M, Foss FM, Roberts KB, Wilson LD. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome. Clin Lymphoma Myeloma Leuk 17(8):520-526.e2, 2017. e-Pub 2017. PMID: 28655598.
62. Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM, Becker KP, Yu JB, Bindra RS, Roberts KB. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro Oncol 19(2):259-269, 2017. e-Pub 2017. PMID: 27540083.
63. Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children. JAMA Oncol 2(12):1574-1581, 2016. e-Pub 2016. PMID: 27491009.
64. Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009. Am J Clin Oncol 39(6):568-574, 2016. e-Pub 2016. PMID: 24879475.
65. Lester-Coll NH, Park HS, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim SP, Gross CP, Yu JB. The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer. Urology 96:128-135, 2016. e-Pub 2016. PMID: 27392652.
66. Kole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme. Cancer 122(15):2364-70, 2016. e-Pub 2016. PMID: 27172136.
67. Rutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base. Cancer 121(23):4141-9, 2015. e-Pub 2015. PMID: 26280559.
68. Rutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation. Lung Cancer 90(2):243-8, 2015. e-Pub 2015. PMID: 26277031.
69. Rutter CE, Lester-Coll NH, Mancini BR, Corso CD, Park HS, Yeboa DN, Gross CP, Evans SB. The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer. Cancer 121(14):2331-40, 2015. e-Pub 2015. PMID: 25810128.
70. Yeboa DN, Aneja S, Montana G, Roberts K, Yu J. Historical Trends in Radiotherapy Use in Prevalent Malignancies over 38 years in SEER. Journal of Radiation Oncology 4(11), 2015. e-Pub 2015.
71. Rutter CE, Corso CD, Park HS, Mancini BR, Yeboa DN, Lester-Coll NH, Kim AW, Decker RH. Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States. Lung Cancer 85(3):390-4, 2014. e-Pub 2014. PMID: 25001510.
72. Yeboa DN, Guzzo T, Mitra N, Christodouleas JP, Haas NB, Vapiwala N, Armstrong K, Bekelman JE. Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology 78(5):1107-13, 2011. e-Pub 2011. PMID: 21943872.
73. Bekelman JE, Mitra N, Efstathiou J, Liao K, Sunderland R, Yeboa DN, Armstrong K. Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys 81(4):e325-34, 2011. e-Pub 2011. PMID: 21498008.

Invited Articles

1. Farooqi A, Li J, de Groot J, Yeboa DN. Current Role of Radiation Therapy in the Management of Malignant Central Nervous System Tumors. Hematol Oncol Clin North Am 34(1):13-28, 2020. e-Pub 2020. PMID: 31739940.
2. Yeboa DN, Shah AY. Managing Perplexing Intracranial Lesions. Int J Radiat Oncol Biol Phys 105(2):24, 2019. e-Pub 2019. PMID: 31492380.
3. Yeboa DN, Sulman E. “Update on radiation combinations in the treatment of patients with malignant brain tumors: from Radiosensitizers to immunotherapy”. World Federation of Neuro-Oncology Societies Magazine, WFNOS Volume 2(Issue 3):ISSN 2518-6507. e-Pub 2017.

Other Articles

1. Pabon CM, Yeboa DN, O'Brien BJ, Majd NK, Wang C, Blum Murphy MA Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature. J Gastrointest Oncol 15(3):1331-1340, 2024. PMID: 38989402.
2. McClelland S, Yeboa DN The Emerging Paradigm of Preoperative Stereotactic Radiosurgery for Resectable Brain Metastases. JAMA Oncol 9(8):1073-1074, 2023. PMID: 37289443.
3. Kim MM, Mehta MP, Smart DK, Steeg PS, Hong JA, Espey MG, Prasanna PG, Crandon L, Hodgdon C, Kozak N, Armstrong TS, Morikawa A, Willmarth N, Tanner K, Boire A, Gephart MH, Margolin KA, Hattangadi-Gluth J, Tawbi H, Trifiletti DM, Chung C, Basu-Roy U, Burns R, Oliva ICG, Aizer AA, Anders CK, Davis J, Ahluwalia MS, Chiang V, Li J, Kotecha R, Formenti SC, Ellingson BM, Gondi V, Sperduto PW, Barnholtz-Sloan JS, Rodon J, Lee EQ, Khasraw M, Yeboa DN, Brastianos PK, Galanis E, Coleman CN, Ahmed MM National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. Lancet Oncol 24(8):e344-e354, 2023. PMID: 37541280.
4. Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, Beckham TH, Bishop AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W, Amini B Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol 96(1141):20220267, 2023. PMID: 35946551.
5. Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, Beckham TH, Bishio AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W, Amini B Multidisciplinary management of spinal metastases: what the radiologist needs to know. Br J Radiol 95(1138):20220266, 2022. PMID: 35856792.
6. Hasanov E, Yeboa DN, Tucker MD, Swanson TA, Beckham TH, Rini B, Ene CI, Hasanov M, Derks S, Smits M, Dudani S, Heng DYC, Brastianos PK, Bex A, Hanalioglu S, Weinberg JS, Hirsch L, Carlo MI, Aizer A, Brown PD, Bilen MA, Chang EL, Jaboin J, Brugarolas J, Choueiri TK, Atkins MB, McGregor BA, Halasz LM, Patel TR, Soltys SG, McDermott DF, Elder JB, Baskaya MK, Yu JB, Timmerman R, Kim MM, Mut M, Markert J, Beal K, Tannir NM, Samandouras G, Lang FF, Giles R, Jonasch E An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma. CA Cancer J Clin 72(5):454-489, 2022. PMID: 35708940.
7. Piña Y, Yadugiri S, Yeboa DN, Ferguson SD, Forsyth PA, Oliva ICG Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma. Curr Oncol Rep 24(1):43-54, 2022. PMID: 35059999.
8. Yeboa DN, Evans SB Contemporary Breast Radiotherapy and Cardiac Toxicity. Semin Radiat Oncol 26(1):71-8, 2016. PMID: 26617212.

Abstracts

1. Nantavithya C, Yeboa DN, Liao K, McGovern S, Grosshans D, McAleer MF, Woodhouse K, Khatua S, Chintagumpala M, Paulino A. Risk of developing secondary malignancies in patients with medulloblastoma receiving beam radiation, a surveillance, epidemiology, and end results (SEER) analysis. 2018 50th Congress of the International Society of Paediatric Oncology, 2018. e-Pub 2018.
2. Miccio JA, Wilson LD, Kann BH, Jairam V, Beckta J, Yeboa DN. “Higher Volume Facilities are Associated with Lower Dose Radiotherapy in the Treatment of Cutaneous T-Cell Lymphoma”. 2018 American Society for Radiation Oncology (ASTRO), 60th Annual Meeting POSTER VIEWING, 2018. e-Pub 2018.
3. Nantavithya C, Yeboa DN, Liao K, McGovern S, Grosshans D, McAleer MF, Woodhouse K, Khatua S, Chintagumpala M, Paulino A. Secondary malignant neoplasms in patients with medulloblastoma. 2018 American Society for Radiation Oncology (ASTRO), 60th Annual Meeting POSTER VIEWING, 2018. e-Pub 2018.
4. Han E, Kim G, Rebeno N, Yeboa DN, Wang X, Lee H, Svensson S, Briere T. E2E test of automatic plan optimization using Raystation scripting for Hypo-fractionated multi-metastatic brain SRS. American Association of Physicists in Medicine National Meeting July 2018 (Nashville TN) Poster, 2018. e-Pub 2018.
5. Miccio JA, Wilson LD, Kann BH, Jairam V, Beckta J, Yeboa DN. “Cutaneous T-Cell Lymphoma: Trends in Radiation Dose and Patterns of Care”. 2018 100th American Radium Society Meeting, Orlando FL, May, 5-8,2018, Poster, 2018. e-Pub 2018.
6. Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Bindra RS, Becker KP, Baehring J, Roberts KB. Addition of Chemotherapy to Adjuvant Radiation Therapy is Associated With Improved Overall Survival in Adult Medulloblastoma. Int J Radiat Oncol Biol Phys 96(2S):S27-S28, 2016. e-Pub 2016. PMID: 27675888.
7. Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Bindra RS, Khan AJ, Marks AM, Roberts KB. Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children. Int J Radiat Oncol Biol Phys 96(2S):S230-S231, 2016. e-Pub 2016. PMID: 27675855.
8. Park HSM, Yeboa DN, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Roberts KB, Yu JB. Pediatric Brainstem Glioma Survival After Definitive Radiation Therapy With or Without Concurrent Chemotherapy: A Nationwide Comparison. International Journal of Radiation Oncology • Biology • Physics 93(3):E504–E505, 2015. e-Pub 2015.
9. Yeboa DN, Park HSM, Rutter CE, Mancini BR, Corso CD, Lester-Coll NH, Bindra RS, Yu JB. Practice Patterns of Concurrent Chemoradiation Therapy Compared to Radiation Therapy Alone for Low Grade Gliomas. Int J Radiat Onc Biol Phys 93(3):E73, 2015. e-Pub 2015.
10. An Y, Rutter CE, Park HSM, Corso CD, Mancini BR, Lester-Coll NH, Yeboa DN, Evans SB. Adoption of Hypofractionated Whole-Breast Irradiation for Ductal Carcinoma In Situ Patients After Breast Conservation Surgery. Int J Radiat Onc Biol Phys 93(3):E54-E55, 2015. e-Pub 2015.
11. Kole AJ, Yeboa DN, Rutter CE, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Yu JB, Park HSM. Survival Benefit of Concurrent Chemoradiation Therapy for Unresected Glioblastoma Multiforme in the Temozolomide Era. Int J Radiat Onc Biol Phys 93(3):E64, 2015. e-Pub 2015.
12. An Y, Rutter CE, Park HSM, Stahl JM, Corso CD, Mancini BR, Lester-Coll NH, Yeboa DN, Evans SB. Increasing Use of Post Lumpectomy Radiation Therapy for Ductal Carcinoma In Situ of the Breast in the United States. Int J Radiat Onc Biol Phys 93(3):E50, 2015. e-Pub 2015.
13. Rutter CE, Park HSM, Corso CD, Lester-Coll NH, Man BR, Yeboa DN. The Addition of Radiation Therapy to Adjuvant Chemotherapy is Associated With Improved Overall Survival in Resected Pancreatic Adenocarcinoma. Int J Radiat Onc Biol Phys 93(3):S154-S155, 2015. e-Pub 2015.
14. Yeboa DN, Rutter CE, Park HSM, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Yu JB. Concurrent Chemoradiation Therapy Is Associated With Improved Survival Compared to Radiation Therapy Alone for Anaplastic Gliomas. Int J Radiat Onc Biol Phys 93(3):S168, 2015. e-Pub 2015.
15. Lester-Coll NH, Park HSM, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim S, Gross CP, Yu JB. Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer. Int J Radiat Onc Biol Phys 93(3):S118, 2015. e-Pub 2015.
16. Yeboa D, Roberts KB, Aneja S, Yu JB. Historical Trends of Radiation Therapy Use in Prevalent Malignancies. Int J Radiat Onc Biol Phys 90(1):S599-S600, 2014. e-Pub 2014.
17. Yeboa D, Yu JB. Impact of the Recession on Radiation Therapy After Lumpectomy for Invasive Breast Cancer. Int J Radiat Onc Biol Phys 87(2):S218, 2013. e-Pub 2013.
18. Yeboa DN, Mitra N, Guzzo T, Pollack C, Bekelman J. Subsequent Treatment Outcomes of Men with Localized Prostate Cancer Who Do Not Receive Initial Treatment. Int J Radiat Onc Biol Phys 81(2):S405, 2011. e-Pub 2011.
19. Bekelman JE, Mitra N, Efstathiou J, Liao K, Sunderland R, Yeboa DN, Armstrong K. Comparative Effectiveness of Intensity Modulated (IMRT) versus 3D Conformal (CRT) Radiotherapy for Non-metastatic Prostate Cancer. Int J Radiat Onc Biol Phys 78(3):S77, 2010. e-Pub 2010.
20. Yeboa DN, Sunderland R, Liao K, Armstrong K, Bekelman J. Trends in Treatment with Intensity Modulated (IMRT) vs. 3D Conformal (CRT) Radiotherapy for Non-metastatic Prostate Cancer. Int J Radiat Onc Biol Phys 78(3):S342-S343, 2010. e-Pub 2010.
21. Taku N, Woodhouse K, Liao K, McGovern S, Grosshans D, Paulino A, Yeboa DN. Patterns of care of pediatric patients diagnosed with grade II gliomas. International Journal of Radiation Oncology • Biology • Physics (IJROBP),.
22. Ludmir E, Liao K, Bishop A, Lin T, McAleer M, Woodhouse K, Paulino A, Yeboa DN. Relationship between Treatment Center Case Volume and Outcomes for Ewing Sarcoma Patients: The Role of Local Therapy Timing. International Journal of Radiation Oncology • Biology • Physics (IJROBP).

Book Chapters

1. Farooqi A, Yeboa DN, Sulman. High Grade Gliomas. In: Pocket Radiation Oncology. 1. Wolters Kluwer, 3-4, 2019.
2. Farooqi A, Yeboa DN, Sulman. Low Grade Gliomas. In: Pocket Radiation Oncology. 1. Wolters Kluwer, 3-1, 2019.
3. Farooqi A, Yeboa DN, Sulman. Meningioma. In: Pocket Radiation Oncology. 1. Wolters Kluwer, 3-8, 2019.
4. Farooqi A, Yeboa DN, Sulman. Pituitary Adenoma and Craniopharyngioma. In: Pocket Radiation Oncology. 1. Wolters Kluwer, 3-15, 2019.
5. Ferguson SD, Everson R, Wagner K, Yeboa DN, McCutcheon IE, Sawaya R. Neurosurgical Management of Single Brain Metastases. In: Adult CNS Radiation Oncology: Principles and Practice. 1st. Springer, 431-448, 2018.
6. Yeboa DN, Young M, Damast, S. Vaginal Cancer. In: Pocket Guide to Radiation Oncology. 1st. Demos Medical Publishing, 2016.

Letters to the Editor

1. De B, Kaiser KW, Ludmir EB, Yeboa DN, Tang C, Hoffman KE, Liao Z, Koong AC, Smith BD. Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncol 60: 312-315, 2021.